ÂÜÀòÂÒÂ×

Drew serves as Chief Executive Officer and is well respected as an innovative, industry thought leader. He has over 30 years of specialty infusion experience, including a successful track record of leading denovo growth market expansion and effectively integrated dozens of strategic acquisitions. Prior to his CEO appointment, he held roles in executive leadership with Accredo Health Group and Critical Care Systems. Drew is a former board member of the National Home Infusion Association (NHIA) and other trade organizations. Drew earned his Bachelor of Science in Pharmacy from St. Louis College of Pharmacy.